LIFR-AS1
gene geneOn this page
Summary
LIFR-AS1 (LIFR antisense RNA 1, HGNC:43600) is a long non-coding RNA gene on chromosome 5p13.1.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:43600 |
| Approved symbol | LIFR-AS1 |
| Name | LIFR antisense RNA 1 |
| Location | 5p13.1 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Ensembl gene | ENSG00000244968 |
| Ensembl biotype | lncRNA |
| Entrez | 100506495 |
| RNAcentral | URS0000490DBB — lncRNA, 3803 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 15 — 15 lncRNA
ENST00000500733, ENST00000500817, ENST00000514291, ENST00000652922, ENST00000657740, ENST00000658674, ENST00000660661, ENST00000661968, ENST00000666123, ENST00000669394, ENST00000670079, ENST00000670215, ENST00000671056, ENST00000671098, ENST00000788940
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000500733 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001965894 | 38607600 | 38608862 |
| ENSE00001984506 | 38556786 | 38559177 |
| ENSE00001984922 | 38594922 | 38595069 |
Expression profiles
Bgee: expression breadth ubiquitous, 156 present calls, max score 78.43.
FANTOM5 (CAGE): breadth broad, TPM avg 1.2675 / max 43.0608, expressed in 614 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 56191 | 1.0047 | 489 |
| 56192 | 0.2628 | 142 |
Top tissues by expression
242 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sural nerve | UBERON:0015488 | 78.43 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 78.14 | gold quality |
| calcaneal tendon | UBERON:0003701 | 77.35 | gold quality |
| mucosa of stomach | UBERON:0001199 | 73.87 | gold quality |
| popliteal artery | UBERON:0002250 | 73.68 | gold quality |
| tibial artery | UBERON:0007610 | 73.68 | gold quality |
| ventricular zone | UBERON:0003053 | 73.65 | gold quality |
| ganglionic eminence | UBERON:0004023 | 73.53 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 71.89 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 71.60 | silver quality |
| prefrontal cortex | UBERON:0000451 | 71.36 | gold quality |
| aorta | UBERON:0000947 | 71.32 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 71.22 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 71.13 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 71.11 | gold quality |
| nucleus accumbens | UBERON:0001882 | 70.95 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 70.94 | gold quality |
| cortical plate | UBERON:0005343 | 70.89 | gold quality |
| amygdala | UBERON:0001876 | 70.68 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 70.61 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 70.58 | gold quality |
| right uterine tube | UBERON:0001302 | 70.46 | gold quality |
| muscle of leg | UBERON:0001383 | 70.35 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 70.31 | gold quality |
| hypothalamus | UBERON:0001898 | 70.24 | gold quality |
| caudate nucleus | UBERON:0001873 | 70.21 | gold quality |
| putamen | UBERON:0001874 | 70.16 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 70.16 | gold quality |
| right frontal lobe | UBERON:0002810 | 70.14 | gold quality |
| left ovary | UBERON:0002119 | 70.12 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 5.48 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 9)
- LIFR-AS1 serves as a competitive endogenous RNA for miR-29a to inhibit its expression and up-regulate downstream target TNFAIP3 expression, finally modulating the resistance of colorectal cancer to pohotodynamic therapy. (PMID:29807108)
- High long non-coding LIFR-AS1 expression correlates with poor survival in gastric carcinoma. (PMID:32495872)
- Long noncoding RNA LIFR-AS1 suppresses proliferation, migration and invasion and promotes apoptosis through modulating miR-4262/NF-kappaB pathway in glioma. (PMID:33070767)
- lncRNA LIFRAS1 inhibits gastric carcinoma cell proliferation, migration and invasion by sponging miR4698. (PMID:33355363)
- M(6)A-mediated up-regulation of LncRNA LIFR-AS1 enhances the progression of pancreatic cancer via miRNA-150-5p/ VEGFA/Akt signaling. (PMID:34658294)
- Long non-coding RNA LIFR-AS1 suppressed the proliferation, angiogenesis, migration and invasion of papillary thyroid cancer cells via the miR-31-5p/SIDT2 axis. (PMID:34781815)
- Long Noncoding RNA LIFR-AS1: A New Player in Human Cancers. (PMID:35071590)
- LncRNA LIFR-AS1 overexpression suppressed the progression of serous ovarian carcinoma. (PMID:35778954)
- Genome-wide screening for differentially methylated long noncoding RNAs identifies LIFR-AS1 as an epigenetically regulated lncRNA that inhibits the progression of colorectal cancer. (PMID:36316703)
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.